Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
4,915
Funds Holding Change
-40
Funds Holding Growth
-0.8%
Value
$1.38T
Holding in Top 10
1,107
Top 10 Change
-47
Top 10 Growth
-4%
Value Growth
-4%
New
148
Increased
1,988
Reduced
2,459
Closed
138
Capital Inflow
$30.7B
Capital Outflow
$48.1B
Net Capital Flow
-$17.5B
Capital Flow Change
-$12.2B
Calls
$22.3B
Puts
$23.9B
Net Calls
-$1.63B
Put/Call Ratio
1.07